Back to Press Releases Press Releases from 2018

Companies around the world are working on better ways to manage diabetes. Universities and other research institutions are working on finding a cure for diabetes and its complications. We provide an outlet for press releases from these organizations, so that you can better understand what they're working on.

Press Releases from 2018

    19 December 2018

  1. Tidepool to Develop Tidepool Loop with New $6M Funding Commitment from Helmsley Charitable Trust and JDRF.

    13 November 2018

  2. Xeris Pharmaceuticals Releases Additional Phase 3 Clinical Trial Data on Its Ready-to-Use Liquid Glucagon Pen.

    31 October 2018

  3. Diabetes Technology Society announces that Insulet Corporation's Omnipod DASH™ System is the first insulin pump evaluated under the DTSec Cybersecurity Standard.

    19 October 2018

  4. JDRF, ADA and Helmsley Charitable Trust Announce Funding of Quantitative Analysis of Insulin Purchased from Pharmacies in the U.S.

    10 October 2018

  5. Tidepool intends to deliver Loop as a supported, FDA-regulated mobile app in the App Store.
  6. Beta Bionics Awarded Up to $2 Million NIH Small Business Innovation Research (SBIR) Grant.
  7. Tech Update: Medtronic Minimed 670G approved in Canada.

    3 October 2018

  8. Results from Two Phase 3 Studies Show Lilly's Ultra Rapid Lispro (URLi) Met Primary Efficacy Endpoint in People with Type 1 and Type 2 Diabetes. See also Ultra-rapid insulin improves postprandial glucose levels in type 1, type 2 diabetes.
  9. Health Canada approves TRESIBA® for children with Type 1 diabetes.
  10. Abbott′s FreeStyle® Libre 2, with Optional Real-Time Alarms, Secures CE Mark for Use in Europe.
  11. Beyond Type 1 Receives $300,985 Helmsley Charitable Trust Grant for DKA Awareness Campaign.

    19 September 2018

  12. Diabetes Scholars - A Program of Beyond Type 1.
  13. Beta Bionics Secures an Initial $50 Million Series B Round.

    12 September 2018

  14. ImmusanT Expands Platform to Type 1 Diabetes with Investment from JDRF T1D Fund.

    29 August 2018

  15. Christina Roth, CEO and Founder of College Diabetes Network, Honored As Boston Business Journal “40 under 40” Recipient.
  16. Children with Diabetes, a leader in diabetes education and support, receives $10,000 foundation charitable grant.
  17. 22 August 2018

  18. Tandem Diabetes Care Announces Commercial Launch of t:slim X2 Insulin Pump with Basal-IQ Technology in the United States.
  19. Ziylo Acquired by Novo Nordisk in Deal That Could Exceed US$800m. See also Bristol university PhD graduate, 31, set to become a multi-millionaire after company he co-founded sells for £600 million and Bristol University graduate sells Ziylo firm in deal worth £623m.
  20. AADE’s DANA: One-Stop Healthcare Technology Resource for Diabetes Educators.
  21. Companion Medical and One Drop Announce Partnership in Integrated Diabetes Management.

    15 August 2018

  22. Xeris Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business Highlights.

    8 August 2018

  23. Tandem Diabetes Care Announces Publication of PROLOG Study Results in Diabetes Care Journal; Study Demonstrates Significant Reduction in Hypoglycemia without Rebound Hyperglycemia.

    1 August 2018

  24. Lilly Diabetes Solution Center Now Open to Help People with Insulin Affordability.
  25. Abbott's FreeStyle® Libre 14 Day Flash Glucose Monitoring System Now Approved in US.
  26. New Insights Revealed in National Survey Show More Advances Are Needed for the Type 1 Diabetes Community.

    19 July 2018

  27. New Lilly Diabetes helpline to Assist People Seeking Solutions to Insulin Affordability.

    27 June 2018

  28. Omnipod® Hybrid Closed-Loop Insulin Delivery System Significantly Improves Glycemic Control in Adults with Type 1 Diabetes.
  29. Tandem Diabetes Care Announces FDA Approval of t:slim X2 Insulin Pump with Basal-IQ Technology; New Predictive Low Glucose Suspend Feature to Launch with Dexcom G6 CGM System Integration.
  30. FDA Approves World's First Long-Term Implantable Continuous Glucose Monitoring System for Marketing in United States.
  31. Fully Implantable, Continuous Glucose Monitoring Sensor Provided Accuracy for Six Months in Adolescents and Adults with Type 1 Diabetes.
  32. Existing drug preserves insulin production in new Type 1 diabetes cases, study finds. See also Kidney drug preserves insulin production in type 1 diabetes patients.
  33. Survey demonstrating underuse of glucagon rescue kits in type 1 diabetes patients to be presented at the ADA's 78th Scientific Sessions.
  34. One Drop Announces Blood Glucose Prediction and Automated Decision Support.

    20 June 2018

  35. Dreamed Diabetes Granted FDA Authorization to Market Advisor Pro, Offering Personalized Optimization of Insulin Pump Therapy.

    13 June 2018

  36. Dexcom G5 Continuous Glucose Monitoring System Now Available on Mobile, Smart Devices for Medicare Patients with Diabetes.
  37. Senseonics and Beta Bionics Partner on Development of the Bionic Pancreas System.

    6 June 2018

  38. Insulet’s Omnipod® DASH™ Insulin Management System Receives FDA 510(k) Clearance.

    23 May 2018

  39. Beta Bionics Receives IDE Approval from the FDA to Begin a Home-Use Clinical Trial Testing the New iLet™️ Bionic Pancreas System. See also Beta Bionics receives FDA approval to begin bionic pancreas study recruitment.
  40. Protomer Technologies Takes Top Prize in 2018 Diabetes Innovation Challenge; Revolutionary “smart” drug could prevent hypoglycemia in people with diabetes.

    16 May 2018

  41. T1D Exchange Co-Founder Dana Ball to Step Down as CEO.

    2 May 2018

  42. American Diabetes Association® Announces Tracey D. Brown, MBA, BChE, as new CEO, effective June 1, 2018.
  43. Tandem is pleased to introduce AutoSoft XC.
  44. Tandem Diabetes Care Receives CE Mark for t:slim X2 Insulin Pump.

    25 April 2018

  45. Tandem Diabetes Care Announces Agreements for Distribution of Insulin Pump Products in Australia and New Zealand.

    4 April 2018

  46. Senseonics Announces Favorable Outcome of FDA Advisory Committee on the Eversense System.
  47. Lilly and Sigilon Therapeutics Announce Strategic Collaboration to Develop Encapsulated Cell Therapies for the Treatment of Type 1 Diabetes.

    28 March 2018

  48. American Diabetes Association® Releases "Economic Costs of Diabetes in the U.S." Report at Annual Call to Congress Event Urging Legislators to Make Diabetes a National Priority.

    21 March 2018

  49. Insulet Expands Access to Omnipod® as an In-Network Provider with United Healthcare.
  50. The New F-Word and its Diabetes Connection.
  51. Moved By Tragic Diabetes Story, Fellow Type 1, Bret Michaels, Looks To Insulin Resolution.

    14 March 2018

  52. Insulet Expands Access to Omnipod® as an In-Network Provider with United Healthcare.
  53. The New F-Word and its Diabetes Connection.
  54. Insulet Has Strong Presence at the International ATTD Congress; Presents Positive Study Results for Its Omnipod Horizonâ„¢ Hybrid Closed-Loop System.
  55. Reduced Time in Hypoglycemia Demonstrated in Tandem Diabetes Care’s Pivotal Trial for the t:slim X2 Insulin Pump with Predictive Low Glucose Suspend Feature; Data to be Presented at ATTD 2018 Conference.
  56. New Study Demonstrates that DexCom CGM Significantly Reduces Hypoglycaemia in People with Type 1 Diabetes on MDI.
  57. Tandem Diabetes Care Applies for Health Canada Medical Device License.
  58. Tackling the Cell Supply Challenge Takes Center Stage in Spain as DRI's Dr. Juan Dominguez-Bendala Discusses Potential Breakthroughs.
  59. Zealand Pharma's dasiglucagon Phase 2a results at the 11th International Conference on ATTD.
  60. SFC Fluidics, Inc. Announces Partnership with JDRF to Develop Pod Device for Automated Insulin Delivery.
  61. JDRF Partners with EOFlow to Develop Wearable Automated Insulin Delivery System for People with Type 1 Diabetes.
  62. Tandem Diabetes Care Reports Successful Completion of First Pilot Study Using t:slim X2 Insulin Pump with TypeZero Hybrid Closed Loop Technology and Dexcom G6 Integration; Confirms IDCL Multi-site Study Timeline.
  63. Abbott's Revolutionary Continuous Glucose Monitoring System, FreeStyle® Libre, Now Available To Medicare Patients.
  64. Livongo and Lilly Collaborate on Real-World Diabetes Research.

[ Recent Press Releases | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 ]

To have your press release included on this page, please use our Feedback Form. Please be sure to include contact information in case we have questions. We reserve the right to include only those press releases that are consistent with our editorial positions.

  Back to Press Releases Return to the Top of This Page

Last Updated: (none)
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.